Marvell’s AI Tailwinds Heating Time: Is Now the Buy?
Marvell Technology rides AI tailwinds into a breakout, delivering record quarterly momentum and a growing pipeline of...
What To Include In A Financial Goal Checklist
What To Include In A Financial Goal Checklist outlines essential items to ensure goals are actionable and measurable.
21,621 articles
Equipment (CVV) 2026 Earnings Outlook: An Investor Guide
Unpack CVV's Q1 2026 transcript to understand what the numbers mean for equipment (cvv) 2026 earnings. This guide bre...
Why Figma Stock Jumped Friday: Q1 Beat Lifts Sentiment
Figma stunned traders with a big Q1 2026 beat, lifting the stock on Friday morning. Here’s what happened, why it matt...
Space ETF Bets Rally as SpaceX IPO Looms
SpaceX rumors spark a rally in the Procure Space ETF, with the fund tracking the space economy as investors eye a pot...
Echo Token Crashes Double After Major Protocol Breach
A large exploit hit Echo Protocol Monday night, sending the ECHO token down and forcing a pause on cross-chain transf...
Guggenheim Just Slapped Rating on StubHub: Buy Target at $12.50
Guggenheim started coverage on StubHub with a Buy rating and a $12.50 price target, signaling optimism for the live-e...
David Tepper Micron Perfect Moment Signals AI Bets
David Tepper's Appaloosa Management has loaded up on Micron as memory markets rebound, while bets on AMZN and UBER re...
Elon Musk’s Proposed Package Sets SpaceX IPO Milestones
SpaceX’s IPO filing reveals Elon Musk’s proposed package, a historic grant that vests only if the company reaches a $...
Bloom Energy’s Rally Has Pushed Too Far, Analysts Warn
Bloom Energy posted a robust Q1 2026 and raised guidance, fueling a sharp stock surge. Yet traders and analysts quest...
Modine Manufacturing Reports Soon: Why Buy Before the Drop
Modine Manufacturing sits at a compelling crossroads as data centers expand. This primer outlines why investors may w...
MIB: Vimal Kapur, Chairman — Honeywell's AI-Driven Growth
Meet MIB: Vimal Kapur, Chairman and CEO of Honeywell, as we dive into his plan to split the company into three units ...
Two Distinct Growth Paths: Johnson & Johnson vs AbbVie
Johnson & Johnson and AbbVie report strong Q1 2026 results, showcasing two contrasting growth paths as biosimilar cha...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status